DHS’ Vice Chairman, Fernando Aguirre, Announces: DHS Opens Offices in London and ZĂĽrich to Manage Control of Investments in Europe
WASHINGTON, DC / ACCESSWIRE / March 30, 2021 / DHS, a multinational private equity and…
WASHINGTON, DC / ACCESSWIRE / March 30, 2021 / DHS, a multinational private equity and…
SAN FRANCISCO, CA / ACCESSWIRE / March 30, 2021 / SMC Entertainment, Inc. (“SMC” or…
SEOUL, SOUTH KOREA / ACCESSWIRE / March 30, 2021 / Public blockchain platform BOSAGORA announced…
CHARLOTTE, NC / ACCESSWIRE / March 30, 2021 / What does life look like when…
MUNICH, GERMANY / ASCHHEIM, GERMANY / AMSTERDAM, NETHERLANDS / ACCESSWIRE / March 30, 2021 /…
SURREY, BC / ACCESSWIRE / March 30, 2021 / Condor Gold (AIM:CNR)(TSX:COG) is pleased to…
CALGARY, AB / ACCESSWIRE / March 30, 2021 / Valeura Energy Inc. (TSX:VLE)(LSE:VLU) (the “Company”…
MOSCOW, RUSSIA and AMSTERDAM. THE NETHERLANDS / ACCESSWIRE / March 30, 2021 / Yandex (NASDAQ:YNDX)(MOEX:YNDX),…
Delivering on strategy to accelerate commercialisation of the Parsortix system and act as a demonstrator…
Bamboo embarks on new market opportunities as it engages with India’s leading value added distributor…
Global Research reveals that the traditional working models no longer apply and faces potential disruption:…
WatchGuard research uncovers massive increases in endpoint attacks, rising rate of encrypted malware and new…
Montreal-based firm selects USU as best-of-breed SAM solution BOSTON, MA – March 30, 2021 –…
Though treasury yields have been rising recently, they remain low by historical standards. In Europe,…
UPPSALA, SWEDEN – LIDDS AB (publ) announced today an update on the clinical program for…
Since the anti-inflammatory effect of the nasally administered Foralumab is through the modulation of the…
Company Announcement Novartis receives European approval for Kesimpta® (ofatumumab) for the treatment of relapsing forms…
Companies have successfully submitted the EU regulatory application for marketing authorization for difelikefalin If approved,…
Expands Novartis Oncology radioligand pipeline with exclusive worldwide rights to develop and commercialize therapeutic applications…
Evrysdi has proven efficacy in adults, children and babies two months and older, as shown…